[Plasma exchange in progressive lupus nephritis]. 1982

A Hörmann, and G Keusch, and R Burger, and J Briner, and U Binswanger, and J Gmür

The clinical course in 8 patients with systemic lupus erythematosus (SLE) complicated by sever lupus nephritis (LN) with progressive renal insufficiency was investigated to evaluate the therapeutic role of plasma exchange in this disease. In 6 patients treated with corticosteroids and immunosuppressive drugs, only a creatinine level exceeding 4.0 mg% resulted in hemodialysis or death. In 2 patients under additional plasma exchange the creatinine value fell below 4.0 mg% and was stabilized at that level over a now lengthy period of time. It cannot yet be concluded that additional plasma exchange definitely prevents hemodialysis. However, stabilization of renal function could optimize conventional therapy, thereby limiting side effects as well as risk of infection.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009393 Nephritis Inflammation of any part of the KIDNEY. Nephritides
D010951 Plasma Exchange Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions. Exchange, Plasma,Exchanges, Plasma,Plasma Exchanges
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Hörmann, and G Keusch, and R Burger, and J Briner, and U Binswanger, and J Gmür
July 1983, The International journal of artificial organs,
A Hörmann, and G Keusch, and R Burger, and J Briner, and U Binswanger, and J Gmür
August 2019, Nephrology (Carlton, Vic.),
A Hörmann, and G Keusch, and R Burger, and J Briner, and U Binswanger, and J Gmür
January 1983, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association,
A Hörmann, and G Keusch, and R Burger, and J Briner, and U Binswanger, and J Gmür
February 2014, Clinical kidney journal,
A Hörmann, and G Keusch, and R Burger, and J Briner, and U Binswanger, and J Gmür
October 1984, Ryumachi. [Rheumatism],
A Hörmann, and G Keusch, and R Burger, and J Briner, and U Binswanger, and J Gmür
June 1990, Nihon Jinzo Gakkai shi,
A Hörmann, and G Keusch, and R Burger, and J Briner, and U Binswanger, and J Gmür
January 1977, Lancet (London, England),
A Hörmann, and G Keusch, and R Burger, and J Briner, and U Binswanger, and J Gmür
June 1979, Journal of the Royal Society of Medicine,
A Hörmann, and G Keusch, and R Burger, and J Briner, and U Binswanger, and J Gmür
January 1979, Advances in nephrology from the Necker Hospital,
A Hörmann, and G Keusch, and R Burger, and J Briner, and U Binswanger, and J Gmür
January 2012, Internal medicine journal,
Copied contents to your clipboard!